National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 1729 [05-383]

Download as PDF Federal Register / Vol. 70, No. 6 / Monday, January 10, 2005 / Notices Dated: January 3, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–390 Filed 1–7–05:8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Conference Meeting (R13) Applications. Date: February 25, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shelley S. Sehnert, PhD, Scientific Review Administrator, Review Branch, NIH/NHLBI, 6701 Rockledge Drive, Room 7206, Bethesda, MD 20892–7492. 301– 435–0303. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, CV Risks in American Indians and Alaskan Natives. Date: March 17, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel & Executive Meeting Center Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: William J. Johnson, PhD, Review Branch, Division of Extramural Affairs, National Heart, Lung and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7184, MSC 7924, Bethesda, MD 20892. 301–435–0275. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Training Grants (K18s, K23s, K24s, and K25s). Date: March 17–18, 2005. VerDate jul<14>2003 18:09 Jan 07, 2005 Jkt 205001 Time: 7 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Roy L. White, PhD, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7192, MSC 7924, Bethesda, MD 20892. 301–435–0287. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS.) Dated: January 3, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–383 Filed 1–7–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Clinical Trials Subcommittee. Date: February 9, 2005. Open: 8 p.m. to 9 p.m. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 1729 Agenda: To discuss clinical trial policy. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Closed: 9 p.m. to 10 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: John Marler, MD, Associate Director for Clinical Trials, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2216, Bethesda, MD 20892. (301) 496–9135. jm137f@nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council, Training, Career Development, and Special Programs Subcommittee. Date: February 9, 2005. Open: 8 p.m. to 9:30 p.m. Agenda: To discuss the training programs of the Institute. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Closed: 9:30 p.m. to 10 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Margaret Jacobs, Acting Training and Special Programs Officer, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2154 MSC 9527, Bethesda, MD 20892–9527. 301–496–4188. mj22o@nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: February 10–11, 2005. Open: February 10, 2005, 8:30 a.m. to 3:45 p.m. Agenda: Report by the Director, NINDS; Report by the Director, Division of Extramural Research; Overview of the NINDS Intramural Program; scientific presentation, and other administrative and program developments. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: February 10, 2005, 3:45 p.m. to 4:45 p.m. Agenda: To review and evaluate the Division of Intramural Research Board of Scientific Counselors’ reports. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: February 11, 2005, 8 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Robert Finkelstein, PhD, Associate Director for Extramural Research, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892. (301) 496–9248. Any interested person may file written comments with the committee by forwarding E:\FR\FM\10JAN1.SGM 10JAN1

Agencies

[Federal Register Volume 70, Number 6 (Monday, January 10, 2005)]
[Notices]
[Page 1729]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-383]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Review of Conference Meeting (R13) 
Applications.
    Date: February 25, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shelley S. Sehnert, PhD, Scientific Review 
Administrator, Review Branch, NIH/NHLBI, 6701 Rockledge Drive, Room 
7206, Bethesda, MD 20892-7492. 301-435-0303.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, CV Risks in American Indians and Alaskan 
Natives.
    Date: March 17, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel & Executive Meeting Center Rockville, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: William J. Johnson, PhD, Review Branch, Division 
of Extramural Affairs, National Heart, Lung and Blood Institute, 
National Institutes of Health, 6701 Rockledge Drive, Room 7184, MSC 
7924, Bethesda, MD 20892. 301-435-0275.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Review of Training Grants (K18s, K23s, K24s, 
and K25s).
    Date: March 17-18, 2005.
    Time: 7 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Roy L. White, PhD, Review Branch, Division of 
Extramural Affairs, National Heart, Lung, and Blood Institute, 
National Institutes of Health, 6701 Rockledge Drive, Room 7192, MSC 
7924, Bethesda, MD 20892. 301-435-0287.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS.)

    Dated: January 3, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-383 Filed 1-7-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.